These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 30471551)
1. Synthesis and evaluation of third generation vitamin D3 analogues as inhibitors of Hedgehog signaling. Maschinot CA; Chau LQ; Wechsler-Reya RJ; Hadden MK Eur J Med Chem; 2019 Jan; 162():495-506. PubMed ID: 30471551 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D3 analogues that contain modified A- and seco-B-rings as hedgehog pathway inhibitors. DeBerardinis AM; Raccuia DS; Thompson EN; Maschinot CA; Kyle Hadden M Eur J Med Chem; 2015 Mar; 93():156-71. PubMed ID: 25676864 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of vitamin D3 analogues with C-11 modifications as inhibitors of Hedgehog signaling. Maschinot CA; Hadden MK Bioorg Med Chem Lett; 2017 Sep; 27(17):4011-4014. PubMed ID: 28780161 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and evaluation of hybrid vitamin D3 side chain analogues as hedgehog pathway inhibitors. Banerjee U; DeBerardinis AM; Hadden MK Bioorg Med Chem; 2015 Feb; 23(3):548-55. PubMed ID: 25549899 [TBL] [Abstract][Full Text] [Related]
5. Structure-Activity Relationship Studies of Vitamin D3 Analogues Containing an Ether or Thioether Linker as Hedgehog Pathway Inhibitors. Wen J; Hadden MK ChemMedChem; 2018 Apr; 13(7):748-753. PubMed ID: 29409113 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships for vitamin D3-based aromatic a-ring analogues as hedgehog pathway inhibitors. Deberardinis AM; Madden DJ; Banerjee U; Sail V; Raccuia DS; De Carlo D; Lemieux SM; Meares A; Hadden MK J Med Chem; 2014 May; 57(9):3724-36. PubMed ID: 24730984 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of vitamin D3 A-ring analogues as Hedgehog pathway inhibitors. Banerjee U; Ghosh M; Kyle Hadden M Bioorg Med Chem Lett; 2012 Feb; 22(3):1330-4. PubMed ID: 22226657 [TBL] [Abstract][Full Text] [Related]
8. Affinity-based protein profiling identifies vitamin D3 as a heat shock protein 70 antagonist that regulates hedgehog transduction in murine basal cell carcinoma. Wen J; Hadden MK Eur J Med Chem; 2022 Jan; 228():114005. PubMed ID: 34844141 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D3 inhibits hedgehog signaling and proliferation in murine Basal cell carcinomas. Tang JY; Xiao TZ; Oda Y; Chang KS; Shpall E; Wu A; So PL; Hebert J; Bikle D; Epstein EH Cancer Prev Res (Phila); 2011 May; 4(5):744-51. PubMed ID: 21436386 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of SANT-2 and analogues as inhibitors of the hedgehog signaling pathway. Büttner A; Seifert K; Cottin T; Sarli V; Tzagkaroulaki L; Scholz S; Giannis A Bioorg Med Chem; 2009 Jul; 17(14):4943-54. PubMed ID: 19541490 [TBL] [Abstract][Full Text] [Related]
11. Probing seco-steroid inhibition of the hedgehog signaling pathway. Thompson EN; Sail V; Raccuia DS; Hadden MK Mol Cell Biochem; 2019 Jan; 450(1-2):75-85. PubMed ID: 29876765 [TBL] [Abstract][Full Text] [Related]
12. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation. Uhmann A; Niemann H; Lammering B; Henkel C; Hess I; Nitzki F; Fritsch A; Prüfer N; Rosenberger A; Dullin C; Schraepler A; Reifenberger J; Schweyer S; Pietsch T; Strutz F; Schulz-Schaeffer W; Hahn H Mol Cancer Ther; 2011 Nov; 10(11):2179-88. PubMed ID: 21878656 [TBL] [Abstract][Full Text] [Related]
13. Identification of vitamin d3-based hedgehog pathway inhibitors that incorporate an aromatic a-ring isostere. DeBerardinis AM; Banerjee U; Hadden MK ACS Med Chem Lett; 2013 Jul; 4(7):590-5. PubMed ID: 24900716 [TBL] [Abstract][Full Text] [Related]
14. Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications. Grund-Gröschke S; Stockmaier G; Aberger F Cell Commun Signal; 2019 Dec; 17(1):172. PubMed ID: 31878932 [TBL] [Abstract][Full Text] [Related]
15. Probing the structural requirements for vitamin D3 inhibition of the hedgehog signaling pathway. DeBerardinis AM; Banerjee U; Miller M; Lemieux S; Hadden MK Bioorg Med Chem Lett; 2012 Jul; 22(14):4859-63. PubMed ID: 22687748 [TBL] [Abstract][Full Text] [Related]
16. Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma. Dormoy V; Béraud C; Lindner V; Coquard C; Barthelmebs M; Brasse D; Jacqmin D; Lang H; Massfelder T Carcinogenesis; 2012 Nov; 33(11):2084-93. PubMed ID: 22843547 [TBL] [Abstract][Full Text] [Related]
17. Hedgehog and Vitamin D Signaling Pathways in Development and Disease. Hadden MK Vitam Horm; 2016; 100():231-53. PubMed ID: 26827954 [TBL] [Abstract][Full Text] [Related]
18. Synthesis, conformational analysis, and biological evaluation of 19-nor-vitamin D3 analogues with A-ring modifications. Sánchez-Abella L; Fernández S; Verstuyf A; Verlinden L; Gotor V; Ferrero M J Med Chem; 2009 Oct; 52(19):6158-62. PubMed ID: 19739672 [TBL] [Abstract][Full Text] [Related]
19. Discovery of Novel Macrocyclic Hedgehog Pathway Inhibitors Acting by Suppressing the Gli-Mediated Transcription. Liu G; Huang W; Wang J; Liu X; Yang J; Zhang Y; Geng Y; Tan W; Zhang A J Med Chem; 2017 Oct; 60(19):8218-8245. PubMed ID: 28873303 [TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold. Berardozzi S; Bernardi F; Infante P; Ingallina C; Toscano S; De Paolis E; Alfonsi R; Caimano M; Botta B; Mori M; Di Marcotullio L; Ghirga F Eur J Med Chem; 2018 Aug; 156():554-562. PubMed ID: 30025349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]